Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Cytek Biosciences has seen ...

Aurora Evo has become the dominant contributor to Aurora Analyzer sales by Q4, driving replacement demand and strong adoption from both pharmaceutical and academic customers since its CYTO launch.

Cytek Biosciences marks the one-year anniversary of its Singapore facility, a strategic hub that has strengthened the company's manufacturing capacity, expanded service and training capabilities ...

Total revenue for the fourth quarter was $62.1 million, an 8% increase compared to the fourth quarter of 2024, and the highest quarterly revenue achieved historically at Cytek Total revenue for the ...

[SINGAPORE] Flow cytometry company Cytek Biosciences has invested US$3 million in its Singapore facility as it expands its manufacturing and regional operations, its chief executive officer said on ...

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek ...

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of $0.02. This compares to earnings of $0.07 per share a year ago. These figures ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you design and create an advertising campaign, in print and digital, on this ...

Cytek Biosciences, Inc. is a life sciences technology company, which engages in the provision of cell analysis tools by leveraging novel technical approaches. Its products include Cytek Aurora CS, ...